Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taclonex as Supplement to Systemic Therapy in Psoriasis
NCT01761019Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Jan 2013
- Primary completion
- Sep 2014
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Taclonex + Hydrogel Patch in plaque psoriasis, sponsored by University of Pittsburgh. Started Jan 2013; status: completed.
02
Drugs
Taclonex + Hydrogel Patch
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01761019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761019.